Hops compound for septic shock treatment
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a natural compound from hops (xanthohumol) can help people with severe septic shock. It's given early, within the first day, alongside standard intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have septic shock that started less than a day ago
- You need to be on a breathing machine with very low oxygen levels (PaO2/FiO2 under 150)
- A bacterial infection must be confirmed
- Your blood levels of procalcitonin must be above 5 and interleukin-6 above 100
- You must not be allergic to hops or anything made from hops
- Your blood pressure must be unstable, requiring IV medications to support it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This trial tests whether using specific safety signals can prevent harm from too much fluid given during septic shock. It may help guide doctors to stop fluids at the right time.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This study tests whether a medicine called anisodamine can improve blood flow in tiny vessels (microcirculation) under your tongue and help stabilize blood pressure in patients with septic shock. It may offer a new way to support recovery in the ICU.
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.